Healthcare provider profile · identity verified

Tracy Lee Phelps, MD

Allopathic & Osteopathic Physicians|Family Medicine · SHELBY, NC · NPI 1154575801

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Tracy Lee Phelps, MD received $60.49 in general payments during 2025 across 4 reported records.

Exact Sciences Corporation accounted for 49.4% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 4 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic, Rybelsus.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 163 claims for Farxiga by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Symbicort by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 168 claims for Ozempic by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Rybelsus by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Wegovy as an associated drug or biological on 183056 records involving 75256 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Wegovy by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$60.49

4 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Exact Sciences Corporation	Unresolved — no canonical attribution shown	$29.85	49.4%	2	2025
AstraZeneca Pharmaceuticals LP	Unresolved — no canonical attribution shown	$16.77	27.7%	1	2025
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$13.87	22.9%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$60.49	4

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit	Device	Exact Sciences Corporation	$29.85	2	2025
Source payment records 2025-03-25 · Exact Sciences Corporation · $15.55 · Open Payments source 2025-10-14 · Exact Sciences Corporation · $14.30 · Open Payments source
BREZTRI Normalized: breztri	Drug	AstraZeneca Pharmaceuticals LP	$16.77	1	2025
Source payment records 2025-06-24 · AstraZeneca Pharmaceuticals LP · $16.77 · Open Payments source
Ozempic Normalized: ozempic	Drug	Novo Nordisk Inc	$13.87	1	2025
Source payment records 2025-08-28 · Novo Nordisk Inc · $13.87 · Open Payments source
Rybelsus Normalized: rybelsus	Drug	Novo Nordisk Inc	$13.87	1	2025
Source payment records 2025-08-28 · Novo Nordisk Inc · $13.87 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
Ozempic ozempic	2025	Ozempic	2024	168	exact normalized	Medicare Part D
Rybelsus rybelsus	2025	Rybelsus	2024	18 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	FARXIGA open payments reported associated product	CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362	Farxiga · 2024 Exact normalized brand match · 1 Part D row	163	27
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	SYMBICORT open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610	Symbicort · 2024 Exact normalized brand match · 1 Part D row	26	11
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Ozempic open payments reported associated product	CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076	Ozempic · 2024 Exact normalized brand match · 1 Part D row	168	29
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Rybelsus open payments reported associated product	CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076	Rybelsus · 2024 Exact normalized brand match · 1 Part D row	18	suppressed by CMS
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Wegovy open payments reported associated product	CMS Open Payments — General Payments 183056 supporting records · 75256 recipient NPIs · example record 1188130070	Wegovy · 2024 Exact normalized brand match · 1 Part D row	15	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	982	262
Amlodipine Besylate	Amlodipine Besylate	752	207
Levothyroxine Sodium	Levothyroxine Sodium	653	163
Omeprazole	Omeprazole	586	160
Losartan Potassium	Losartan Potassium	553	146
Gabapentin	Gabapentin	517	143
Lisinopril	Lisinopril	476	137
Trazodone Hcl	Trazodone Hcl	416	110
Hydrochlorothiazide	Hydrochlorothiazide	383	109
Metformin Hcl	Metformin Hcl	318	79
Metoprolol Tartrate	Metoprolol Tartrate	293	72
Lorazepam	Lorazepam	285	44
Albuterol Sulfate Hfa	Albuterol Sulfate	283	93
Pantoprazole Sodium	Pantoprazole Sodium	283	76
Escitalopram Oxalate	Escitalopram Oxalate	282	78
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	276	53
Pravastatin Sodium	Pravastatin Sodium	275	68
Furosemide	Furosemide	265	82
Metoprolol Succinate	Metoprolol Succinate	265	76
Glimepiride	Glimepiride	259	69
Sertraline Hcl	Sertraline Hcl	254	73
Tramadol Hcl	Tramadol Hcl	250	49
Carvedilol	Carvedilol	238	71
Montelukast Sodium	Montelukast Sodium	235	66
Eliquis	Apixaban	234	47
Simvastatin	Simvastatin	232	63
Duloxetine Hcl	Duloxetine Hcl	225	58
Clonazepam	Clonazepam	221	29
Potassium Chloride	Potassium Chloride	217	61
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	216	66
Fluoxetine Hcl	Fluoxetine Hcl	207	53
Prednisone	Prednisone	202	124
Fluticasone Propionate	Fluticasone Propionate	200	77
Tizanidine Hcl	Tizanidine Hcl	200	56
Bupropion Xl	Bupropion Hcl	197	60
Alprazolam	Alprazolam	194	21
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	190	27
Rosuvastatin Calcium	Rosuvastatin Calcium	184	50
Clopidogrel	Clopidogrel Bisulfate	180	50
Ozempic	Semaglutide	168	29
Farxiga	Dapagliflozin Propanediol	163	27
Buspirone Hcl	Buspirone Hcl	160	45
Famotidine	Famotidine	155	52
Allopurinol	Allopurinol	154	41
Diclofenac Sodium	Diclofenac Sodium	154	42
Zolpidem Tartrate	Zolpidem Tartrate	153	25
Metformin Hcl Er	Metformin Hcl	132	38
Ropinirole Hcl	Ropinirole Hcl	130	35
Alendronate Sodium	Alendronate Sodium	125	32
Pregabalin	Pregabalin	121	25
Fluconazole	Fluconazole	119	62
Synthroid	Levothyroxine Sodium	116	27
Tamsulosin Hcl	Tamsulosin Hcl	114	37
Topiramate	Topiramate	113	27
Meloxicam	Meloxicam	111	29
Doxycycline Hyclate	Doxycycline Hyclate	110	85
Benazepril Hcl	Benazepril Hcl	109	28
Oxycodone Hcl	Oxycodone Hcl	106	suppressed
Linzess	Linaclotide	105	28
Oxybutynin Chloride Er	Oxybutynin Chloride	103	37
Cephalexin	Cephalexin	102	67
Warfarin Sodium	Warfarin Sodium	99	21
Dicyclomine Hcl	Dicyclomine Hcl	95	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	85	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	85	20
Hydralazine Hcl	Hydralazine Hcl	83	18
Clonidine Hcl	Clonidine Hcl	82	25
Mirtazapine	Mirtazapine	81	29
Amitriptyline Hcl	Amitriptyline Hcl	79	15
Amoxicillin	Amoxicillin	77	64
Promethazine Hcl	Promethazine Hcl	77	23
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	76	66
Venlafaxine Hcl Er	Venlafaxine Hcl	76	15
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	75	36
Meclizine Hcl	Meclizine Hcl	73	33
Hydroxyzine Hcl	Hydroxyzine Hcl	68	22
Citalopram Hbr	Citalopram Hydrobromide	66	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	66	15
Lansoprazole	Lansoprazole	65	13
Pioglitazone Hcl	Pioglitazone Hcl	65	19
Paroxetine Hcl	Paroxetine Hcl	64	22
Sumatriptan Succinate	Sumatriptan Succinate	64	13
Triamcinolone Acetonide	Triamcinolone Acetonide	64	31
Esomeprazole Magnesium	Esomeprazole Magnesium	63	16
Methylprednisolone	Methylprednisolone	63	56
Spironolactone	Spironolactone	62	22
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	61	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	60	19
Ibuprofen	Ibuprofen	58	17
Nystatin	Nystatin	58	32
Ondansetron Odt	Ondansetron	57	34
Lovastatin	Lovastatin	56	16
Quetiapine Fumarate	Quetiapine Fumarate	55	16
Fenofibrate	Fenofibrate Nanocrystallized	54	17
Donepezil Hcl	Donepezil Hcl	53	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	17
Propranolol Hcl	Propranolol Hcl	52	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	50	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	50	30
Valacyclovir	Valacyclovir Hcl	49	21
Ciprofloxacin Hcl	Ciprofloxacin Hcl	45	29
Azithromycin	Azithromycin	44	33
Baclofen	Baclofen	44	12
Naproxen	Naproxen	43	suppressed
Ezetimibe	Ezetimibe	42	13
Klor-Con M20	Potassium Chloride	42	16
Valsartan	Valsartan	42	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	41	12
Celecoxib	Celecoxib	40	11
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	40	suppressed
Tresiba Flextouch U-100	Insulin Degludec	40	suppressed
Fenofibrate	Fenofibrate	39	11
Bupropion Hcl	Bupropion Hcl	38	suppressed
Diazepam	Diazepam	38	suppressed
Glipizide	Glipizide	37	suppressed
Jardiance	Empagliflozin	36	suppressed
Levetiracetam	Levetiracetam	36	suppressed
Nitroglycerin	Nitroglycerin	36	25
Oxybutynin Chloride	Oxybutynin Chloride	34	suppressed
Trulicity	Dulaglutide	34	suppressed
Doxepin Hcl	Doxepin Hcl	33	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	31	suppressed
Atenolol	Atenolol	30	suppressed
Ventolin Hfa	Albuterol Sulfate	30	15
Azelastine Hcl	Azelastine Hcl	28	16
Ciclopirox	Ciclopirox	28	11
Rabeprazole Sodium	Rabeprazole Sodium	28	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	28	suppressed
Tresiba Flextouch U-200	Insulin Degludec	27	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Estradiol	Estradiol	26	suppressed
Ketoconazole	Ketoconazole	26	14
Mupirocin	Mupirocin	26	16
Nifedipine Er	Nifedipine	26	suppressed
Symbicort	Budesonide/Formoterol Fumarate	26	11
Hydroxyzine Pamoate	Hydroxyzine Pamoate	25	suppressed
Novolog Flexpen	Insulin Aspart	25	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	25	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Mounjaro	Tirzepatide	22	suppressed
Flecainide Acetate	Flecainide Acetate	21	suppressed
Humalog Kwikpen U-100	Insulin Lispro	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	18
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Clobetasol Propionate	Clobetasol Propionate	19	suppressed
Folic Acid	Folic Acid	19	suppressed
Dapagliflozin	Dapagliflozin Propanediol	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Enulose	Lactulose	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	11
Repatha Sureclick	Evolocumab	18	suppressed
Rybelsus	Semaglutide	18	suppressed
Tiadylt Er	Diltiazem Hcl	18	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Clindamycin Hcl	Clindamycin Hcl	17	suppressed
Colestipol Hcl	Colestipol Hcl	17	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	17	suppressed
Dexlansoprazole Dr	Dexlansoprazole	17	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	17	suppressed
Raloxifene Hcl	Raloxifene Hcl	17	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	16	suppressed
Temazepam	Temazepam	16	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Liothyronine Sodium	Liothyronine Sodium	15	suppressed
Novolog Mix 70-30	Insulin Aspart Prot/Insuln Asp	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Wegovy	Semaglutide	15	suppressed
Metronidazole	Metronidazole	14	12
Nabumetone	Nabumetone	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Clotrimazole	Clotrimazole	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Lurasidone Hcl	Lurasidone Hcl	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Telmisartan	Telmisartan	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$60.49 · 4 records	Exact Sciences Corporation	BREZTRI, Ozempic, Rybelsus, The Cologuard Plus Collection Kit	5	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Ozempic play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error